Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor of Orthopaedic Trauma Surgery, Matt Costa has been awarded a new trial starting this January 2016, on wound healing in trauma.

The £1.6m trial will address key research questions and aims to improve care and reduce the socioeconomic burden of trauma worldwide.

The Wound Healing In Surgery for Trauma (WHIST) trial will compare wound healing and costs associated with different types of wound dressing for major trauma surgery.

"Infection following surgery for traumatic injuries is a major problem for patients; it can lead to permanent disability and even amputation." says Professor Costa. "The WHIST Trial is funded by the National Institute for Health Research and will investigate new types of wound dressing which may help to reduce the risk of infection.

 

Infection following surgery for traumatic injuries is a major problem for patients; it can lead to permanent disability and even amputation. - Professor Costa

 

"This is one of the largest surgical trials ever performed in the UK. Delivering such a large trial in the context of emergency surgery is challenging but thanks to the NIHR Musculoskeletal Trauma Trials Network, and specifically the Trauma Trainees Collaborative, we are confident we can successfully deliver this important project."

Major trauma is the leading cause of death in people under 45 years and a significant cause of short and long-term disability. It occurs when a patient sustains very serious injuries to one part of the body or injuries to several parts of the body at the same time.

It is estimated major trauma costs the health service between £0.3 and £0.4 billion a year in early hospital treatment, however as it affects primarily young working people the cost to society due to lost economic output is between £3.3 billion and £3.7 billion.

These patients often require surgery, but face infection rates in surgical wounds as high as 40% because the damaged muscle and tissue from the injury are less able to resist the bacteria that cause infections.

With deep infection around the bone causing long-term problems for the patient, often requiring repeated operations and potentially leading to amputation of the lower limbs, it is crucial to improve infection rates for major trauma patients.

One of the factors that may reduce the risk of infection in the surgical wounds of major trauma patients is the type of dressing applied over the wound at the end of the operation.

Negative pressure wound therapy (NPWT) is a type of dressing that involves applying gentle suction to the surface of the wound as it heals and has provided promising early results in patients with surgical wounds associated with major trauma.

WHIST will compare NPWT with standard dressings for patients with surgical wounds associated with major trauma to the lower limb, through a large randomised clinical trial.

WHIST logo

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.